Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Alzheimer’s disease (AD) is an incurable neurodegenerative disease. Numerous studies have demonstrated a critical role for dysregulated glucose metabolism in its pathogenesis. In this review, we summarize metabolic alterations in aging brain and AD-related metabolic deficits associated with glucose...
Main Authors: | Xu Yan, Yue Hu, Biyao Wang, Sijian Wang, Xinwen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2020.530219/full |
Similar Items
-
Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis
by: Alexis Catala, et al.
Published: (2020-04-01) -
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
by: Tesfaye Wolde Tefera, et al.
Published: (2021-01-01) -
Metabolic Insight of Neutrophils in Health and Disease
by: Sachin Kumar, et al.
Published: (2019-09-01) -
Accelerated Metabolite Levels of Aerobic Glycolysis and the Pentose Phosphate Pathway Are Required for Efficient Replication of Infectious Spleen and Kidney Necrosis Virus in Chinese Perch Brain Cells
by: Xixi Guo, et al.
Published: (2019-09-01) -
Can Alternative Metabolic Pathways and Shunts Overcome Salinity Induced Inhibition of Central Carbon Metabolism in Crops?
by: Ali Bandehagh, et al.
Published: (2020-08-01)